Plasmodium Vivax Transmission-blocking Vaccine(Niaid)

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NamePlasmodium Vivax Transmission-blocking Vaccine(Niaid)
Drug Alias NamePlasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M(Niaid)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A